Conference Coverage

Gap in osteoporosis diagnosis and treatment stirs concern


 

AT ASBMR

Pages

Recommended Reading

Worsening osteoporosis care for RA patients shows need for action
MDedge Family Medicine
Study finds low risk for jaw osteonecrosis with denosumab for postmenopausal osteoporosis
MDedge Family Medicine
Reduced fracture risk maintained in abaloparatide extension study
MDedge Family Medicine
Incidental hip CT scans could serve as osteoporosis screen
MDedge Family Medicine
PBC linked to increased risk of bone fracture
MDedge Family Medicine
Preferred osteoporosis treatment order with teriparatide, denosumab reaffirmed
MDedge Family Medicine
Teriparatide reduces fractures over risedronate in all subgroups with osteoporosis
MDedge Family Medicine
Romosozumab reduces fracture risk out to 36 months, with no signs of cardiovascular problems
MDedge Family Medicine
ACP osteoporosis treatment guideline debated
MDedge Family Medicine
Biologic may bring relief for children and adults with XLH syndrome
MDedge Family Medicine

Related Articles